Ruth Navarro‐Artieda

1.3k total citations
106 papers, 1.0k citations indexed

About

Ruth Navarro‐Artieda is a scholar working on Economics and Econometrics, Epidemiology and Physiology. According to data from OpenAlex, Ruth Navarro‐Artieda has authored 106 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 19 papers in Epidemiology and 18 papers in Physiology. Recurrent topics in Ruth Navarro‐Artieda's work include Health Systems, Economic Evaluations, Quality of Life (17 papers), Diabetes Treatment and Management (11 papers) and Diabetes Management and Research (9 papers). Ruth Navarro‐Artieda is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (17 papers), Diabetes Treatment and Management (11 papers) and Diabetes Management and Research (9 papers). Ruth Navarro‐Artieda collaborates with scholars based in Spain, United States and France. Ruth Navarro‐Artieda's co-authors include Antoni Sicras‐Mainar, Javier Rejas, Jorge Mauriño, J.M. Carrascosa, Antoni Sicras, Marion Kvasz, José Carlos Armario Hita, Josep Darbà, Lorenzo Aguilar and Silvia Díaz‐Cerezo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMC Public Health.

In The Last Decade

Ruth Navarro‐Artieda

101 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Navarro‐Artieda Spain 18 187 186 169 161 126 106 1.0k
Feride Frech United States 13 264 1.4× 251 1.3× 143 0.8× 276 1.7× 103 0.8× 41 2.0k
Madge Vickers United Kingdom 14 87 0.5× 329 1.8× 66 0.4× 131 0.8× 170 1.3× 23 1.2k
Trent McLaughlin United States 17 236 1.3× 273 1.5× 92 0.5× 181 1.1× 138 1.1× 50 994
Gero Langer Germany 17 132 0.7× 182 1.0× 95 0.6× 65 0.4× 133 1.1× 72 1.0k
Chris M Kozma United States 24 880 4.7× 288 1.5× 154 0.9× 214 1.3× 160 1.3× 98 2.0k
Mehmet İlkin Naharcı Türkiye 18 100 0.5× 142 0.8× 89 0.5× 57 0.4× 195 1.5× 87 952
Diana Gavrila Spain 16 111 0.6× 195 1.0× 171 1.0× 56 0.3× 152 1.2× 26 1.1k
Scott M. Brue United States 10 126 0.7× 96 0.5× 190 1.1× 50 0.3× 62 0.5× 12 912
Claire Smith United Kingdom 11 116 0.6× 136 0.7× 47 0.3× 71 0.4× 82 0.7× 19 920
Jamie N. Brown United States 19 92 0.5× 81 0.4× 76 0.4× 48 0.3× 60 0.5× 69 911

Countries citing papers authored by Ruth Navarro‐Artieda

Since Specialization
Citations

This map shows the geographic impact of Ruth Navarro‐Artieda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Navarro‐Artieda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Navarro‐Artieda more than expected).

Fields of papers citing papers by Ruth Navarro‐Artieda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Navarro‐Artieda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Navarro‐Artieda. The network helps show where Ruth Navarro‐Artieda may publish in the future.

Co-authorship network of co-authors of Ruth Navarro‐Artieda

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Navarro‐Artieda. A scholar is included among the top collaborators of Ruth Navarro‐Artieda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Navarro‐Artieda. Ruth Navarro‐Artieda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capel, Margarita, et al.. (2018). PRS70 - REAL-LIFE RETROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE AND ECONOMIC BURDEN OF SEVERE ASTHMA. Value in Health. 21. S416–S416. 2 indexed citations
2.
Sicras‐Mainar, Antoni, et al.. (2018). Prevalence of Severe Atopic Dermatitis in Adults in 3 Areas of Spain. Journal of Investigational Allergology and Clinical Immunology. 28(3). 195–197. 11 indexed citations
3.
Sicras‐Mainar, Antoni, et al.. (2017). Impact on healthcare resource utilization of multiple sclerosis in Spain. BMC Health Services Research. 17(1). 854–854. 28 indexed citations
4.
5.
Sicras‐Mainar, Antoni, et al.. (2017). Uso de recursos y costes asociados a la no adherencia al tratamiento con corticoides inhalados en el asma. Medicina de Familia SEMERGEN. 44(1). 13–22. 12 indexed citations
6.
Sicras‐Mainar, Antoni, et al.. (2016). The Economic Burden of Multiple Sclerosis in Spain: A Population Based Study. Value in Health. 19(7). A613–A614. 1 indexed citations
7.
8.
Sicras‐Mainar, Antoni, et al.. (2014). Influence of the CYP2D6 Isoenzyme in Patients Treated with Venlafaxine for Major Depressive Disorder: Clinical and Economic Consequences. PLoS ONE. 9(11). e90453–e90453. 8 indexed citations
9.
Sicras‐Mainar, Antoni & Ruth Navarro‐Artieda. (2014). Healthcare Costs of the Combination of Metformin/Dipeptidyl Peptidase-4 Inhibitors Compared with Metformin/Other Oral Antidiabetes Agents in Patients with Type 2 Diabetes and Metabolic Syndrome. Diabetes Technology & Therapeutics. 16(11). 722–727. 6 indexed citations
10.
Navarro‐Artieda, Ruth, et al.. (2013). Influence of combinations of drugs that act on the CYP2D6 metabolic pathway in the treatment of major depressive disorder: A population-based study. European Psychiatry. 29(6). 331–337. 3 indexed citations
11.
Sicras‐Mainar, Antoni, et al.. (2013). Cost comparison of adding pregabalin or gabapentin for the first time to the therapy of patients with painful axial radiculopathy treated in Spain.. PubMed. 31(3). 372–81. 2 indexed citations
12.
13.
14.
Sicras‐Mainar, Antoni, et al.. (2010). Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences. Current Medical Research and Opinion. 26(12). 2757–2764. 9 indexed citations
15.
Sicras‐Mainar, Antoni, et al.. (2010). Impacto de la morbilidad, uso de recursos y costes en el mantenimiento de la remisión de la depresión mayor en España: estudio longitudinal de ámbito poblacional. Hispana. 13 indexed citations
16.
Sicras‐Mainar, Antoni, Jaime Fernández de Bobadilla, Ruth Navarro‐Artieda, & Javier Rejas. (2010). Mortalidad por cualquier causa e incidencia de enfermedad cardiovascular en hipertensos con perfil tipo Anglo-Scandinavian Cardiac Outcomes Trial en un ámbito poblacional español. Atención Primaria. 42(8). 420–430. 3 indexed citations
17.
Sicras‐Mainar, Antoni, et al.. (2010). Clinical validity of a population database definition of remission in patients with major depression. BMC Public Health. 10(1). 64–64. 11 indexed citations
18.
19.
20.
Sicras‐Mainar, Antoni, et al.. (2007). Adjusted Clinical Groups use as a measure of the referrals efficiency from primary care to specialized in Spain. European Journal of Public Health. 17(6). 657–663. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feride Frech Breakdown of academic impact, for papers by Madge Vickers Breakdown of academic impact, for papers by Trent McLaughlin Breakdown of academic impact, for papers by Gero Langer Breakdown of academic impact, for papers by Chris M Kozma Breakdown of academic impact, for papers by Mehmet İlkin Naharcı Breakdown of academic impact, for papers by Diana Gavrila Breakdown of academic impact, for papers by Scott M. Brue Breakdown of academic impact, for papers by Claire Smith Breakdown of academic impact, for papers by Jamie N. Brown
Rankless by CCL
2026